EP 1040123 A2 20001004 - HUMAN PAPILLOMAVIRUS VACCINE
Title (en)
HUMAN PAPILLOMAVIRUS VACCINE
Title (de)
IMPFSTOFF FÜR DAS HUMANE PAPILLOM-VIRUS
Title (fr)
VACCIN
Publication
Application
Priority
- EP 9808563 W 19981218
- GB 9727262 A 19971224
Abstract (en)
[origin: WO9933868A2] The present invention provides Human Papilloma Virus (HPV) fusion proteins, linked to an immunological fusion partner that provides T helper epiptopes to the HPV antigen. Vaccine formulations are provided that are useful in the treatment or Prophylaxis of HPV induced tumours.
IPC 1-7
IPC 8 full level
C12N 15/09 (2006.01); A61K 39/00 (2006.01); A61K 39/015 (2006.01); A61K 39/02 (2006.01); A61K 39/04 (2006.01); A61K 39/09 (2006.01); A61K 39/095 (2006.01); A61K 39/10 (2006.01); A61K 39/102 (2006.01); A61K 39/104 (2006.01); A61K 39/106 (2006.01); A61K 39/112 (2006.01); A61K 39/118 (2006.01); A61K 39/12 (2006.01); A61K 39/21 (2006.01); A61K 39/385 (2006.01); A61K 39/39 (2006.01); A61P 31/04 (2006.01); A61P 31/18 (2006.01); A61P 33/04 (2006.01); A61P 33/06 (2006.01); A61P 35/00 (2006.01); A61P 37/04 (2006.01); C07K 14/025 (2006.01); C07K 19/00 (2006.01); A61K 38/00 (2006.01)
CPC (source: EP KR)
A61K 39/02 (2013.01 - EP); A61K 39/092 (2013.01 - EP); A61K 39/12 (2013.01 - EP); A61K 39/39 (2013.01 - EP); A61P 31/04 (2018.01 - EP); A61P 31/18 (2018.01 - EP); A61P 31/20 (2018.01 - EP); A61P 33/04 (2018.01 - EP); A61P 33/06 (2018.01 - EP); A61P 35/00 (2018.01 - EP); A61P 37/04 (2018.01 - EP); C07K 14/00 (2013.01 - KR); C07K 14/005 (2013.01 - EP); A61K 38/00 (2013.01 - EP); A61K 2039/55561 (2013.01 - EP); A61K 2039/585 (2013.01 - EP); A61K 2039/6068 (2013.01 - EP); C07K 2319/00 (2013.01 - EP); C12N 2710/20022 (2013.01 - EP); C12N 2710/20034 (2013.01 - EP); Y02A 50/30 (2018.01 - EP)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9933868 A2 19990708; WO 9933868 A3 19990916; AR 014181 A1 20010207; AR 014182 A1 20010207; AT E310535 T1 20051215; AU 2419099 A 19990719; AU 2419199 A 19990719; AU 729336 B2 20010201; AU 736099 B2 20010726; BR 9814483 A 20001010; BR 9814487 A 20001010; CA 2314186 A1 19990708; CA 2314186 C 20110208; CA 2315276 A1 19990708; CN 1284884 A 20010221; CN 1284885 A 20010221; CO 5070644 A1 20010828; CO 5070674 A1 20010828; DE 69832521 D1 20051229; DE 69832521 T2 20060614; EP 1039930 A2 20001004; EP 1039930 B1 20051123; EP 1040123 A2 20001004; ES 2251124 T3 20060416; GB 9727262 D0 19980225; HU P0100526 A2 20010628; HU P0103085 A1 20011128; HU P0103085 A3 20041028; IL 136446 A0 20010614; IL 136447 A0 20010614; JP 2001527050 A 20011225; JP 2001527091 A 20011225; KR 20010033613 A 20010425; KR 20010033618 A 20010425; NO 20003302 D0 20000623; NO 20003302 L 20000818; NO 20003303 D0 20000623; NO 20003303 L 20000804; NZ 505107 A 20030328; NZ 505108 A 20021025; PL 341698 A1 20010423; PL 341761 A1 20010507; TR 200001835 T2 20001221; TR 200001946 T2 20001121; WO 9933488 A2 19990708; WO 9933488 A3 19990902; ZA 9811848 B 20000626; ZA 9811849 B 20000623
DOCDB simple family (application)
EP 9808563 W 19981218; AR P980106677 A 19981223; AR P980106678 A 19981223; AT 98966705 T 19981218; AU 2419099 A 19981218; AU 2419199 A 19981218; BR 9814483 A 19981218; BR 9814487 A 19981218; CA 2314186 A 19981218; CA 2315276 A 19981218; CN 98813794 A 19981218; CN 98813795 A 19981218; CO 98076596 A 19981224; CO 98076598 A 19981224; DE 69832521 T 19981218; EP 9808562 W 19981218; EP 98966705 A 19981218; EP 98966706 A 19981218; ES 98966705 T 19981218; GB 9727262 A 19971224; HU P0100526 A 19981218; HU P0103085 A 19981218; IL 13644698 A 19981218; IL 13644798 A 19981218; JP 2000526239 A 19981218; JP 2000526542 A 19981218; KR 20007007126 A 20000624; KR 20007007131 A 20000624; NO 20003302 A 20000623; NO 20003303 A 20000623; NZ 50510798 A 19981218; NZ 50510898 A 19981218; PL 34169898 A 19981218; PL 34176198 A 19981218; TR 200001835 T 19981218; TR 200001946 T 19981218; ZA 9811848 A 19981223; ZA 9811849 A 19981223